Vertex Pharma scientist talks about the long road to developing non
Time:2024-05-21 14:16:56 Source:businessViews(143)
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Previous:NBA playoffs: Edwards leads Wolves to 98
Next:With Djokovic awaiting the winner, Murray trails Hanfmann at rain
You may also like
- The government wants to buy their flood
- Dance festival celebrates ethnic unity
- Xi Sends Condolences to Biden over Kissinger's Death
- Xi Focus: China's Leadership Holds Symposium for Soliciting Advice on Economic Work
- The fightback begins: Boss of London's Queen Mary University tells pro
- Xi Sends Congratulatory Letter to Liangzhu Forum
- Xi Focus: Xi's Shanghai Inspection Tour Sends Signal of High
- China Focus: Xi Urges Enhanced China
- French sports minister calls for sanctions after Monaco player tapes over anti